Gender Differences at Admission and Follow-up in a Sample of Methadone Maintenance Clients

10.1080/02791072.1994.10472438

10.1016/0376-8716(96)01235-5

Chatham L. R., 1995, J. Stud. Alcohol, 56, 417, 10.15288/jsa.1995.56.417

10.1016/S0306-4603(96)00005-6

Chatham L. R., 1994, Delivering and evaluating outpatient treatment: Finding a practical balance, 181

10.1001/jama.267.2.281

10.3109/00952999709001686

10.1037/0893-164X.9.3.195

10.1037/0022-0167.40.4.385

10.1001/jama.267.2.253

Ellingwood E. H., 1996, Int. J. Addict., 1, 33, 10.3109/10826086609026750

10.1037/0893-164X.11.4.244

Gerstein D. R., 1990, A Study of the Evolution, Effectiveness, and Financing of Public and Private Drug Treatment Systems, 1

Graeven D. B., 1978, Int. J. Addict., 13, 747, 10.3109/10826087809039300

10.1300/J251v04n01_04

Hiller M. L., J. Maintenance Addict

Hubbard R. L., 1989, A National Study of Effectiveness

Joe G. W., 1993, Development of Composite Variables from DATAR Intake Interview

Knight K., 1994, Manual on Psychometric Properties

10.3109/00952998609016873

Rowan-Szal G. A., 1998, Is What You Need What You Get?

Savage L. J., 1980, J. Psychedelic Drugs, 12, 55, 10.1080/02791072.1980.10471552

10.3109/00952998109016914

10.1001/archpsyc.1981.01780330033003

Simpson D. D, 1992, Improving Drug Abuse Treatment for AIDS-Risk Reduction (DATAR) Project

Simpson D. D., 1994, Psychol. Addict. Behav., 8, 86, 10.1037/0893-164X.8.2.86

Simpson D. D., 1993, Cognitive enhancements to treatment in DATAR: Drug abuse treatment for AIDS risks reduction, 161

Simpson D. D., 1997, The Effectiveness of Innovative Approaches in the Treatment of Drug Abuse, 182

10.1037/0033-3204.30.2.357

10.1177/002204269702700205

Simpson D. D., 1995, J. Substance Abuse, 7, 117, 10.1016/0899-3289(95)90309-7

Simpson D. D., 1976, Statistics on Characteristics of Drug Users in Treatment during 1969–1974

Toneatto A., 1992, J. Substance Abuse, 4, 209, 10.1016/0899-3289(92)90020-X

Turner S., 1992, J. Res. Crime Delinq., 29, 34, 10.1177/0022427892029001003

Wechsberg W. M., 1998, Drugs Soc., 13, 97, 10.1300/J023v13n01_06

10.3109/00952999609001677